Injectable Myocardial Matrix Hydrogel Mitigates Negative Left Ventricular Remodeling in a Chronic Myocardial Infarction Model

A first-in-man clinical study on a myocardial-derived decellularized extracellular matrix hydrogel suggested the potential for efficacy in chronic myocardial infarction (MI) patients. However, little is understood about the mechanism of action in chronic MI. In this study, the authors investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, Miranda D., Tran, Elaine, Spang, Martin, Wang, Raymond, Gaetani, Roberto, Luo, Colin G., Braden, Rebecca, Hill, Ryan C., Hansen, Kirk C., DeMaria, Anthony N., Christman, Karen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Preclinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093531/
https://www.ncbi.nlm.nih.gov/pubmed/33997521
http://dx.doi.org/10.1016/j.jacbts.2021.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093531/
https://www.ncbi.nlm.nih.gov/pubmed/33997521
http://dx.doi.org/10.1016/j.jacbts.2021.01.003

Ejemplares similares